Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 2, 2004

 

Commission File Number  0-16960

 


 

THE GENLYTE GROUP INCORPORATED

 

10350 ORMSBY PARK PLACE

SUITE 601

LOUISVILLE, KY  40223

(502) 420-9500

 

Incorporated in Delaware

 

I.R.S. Employer

 

 

Identification No. 22-2584333

 

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                                                                      ý  Yes  No  o

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).                ý  Yes  No  o

 

The number of shares outstanding of the issuer’s common stock as of October 31, 2004 was 13,751,056

 

 



 

THE GENLYTE GROUP INCORPORATED AND SUBSIDIARIES

FORM 10-Q

FOR THE QUARTER ENDED OCTOBER 2, 2004

 

CONTENTS

 

PART I.
FINANCIAL INFORMATION
1
 
 
 
 
ITEM 1.
FINANCIAL STATEMENTS
1
 
 
 

 

Consolidated Statements of Income for the three months and nine months ended October 2, 2004 and September 27, 2003

1

 

 

 

 

Consolidated Balance Sheets as of October 2, 2004 and December 31, 2003

2

 

 

 

 

Consolidated Statements of Cash Flows for the nine months ended October 2, 2004 and September 27, 2003

3

 

 

 

 

Notes to Consolidated Interim Financial Statements

4

 

 

 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

17

 

 

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

29

 

 

 

 

 

 

 

ITEM 4. CONTROLS AND PROCEDURES

30

 

 

 

PART II.
OTHER INFORMATION
31
 
 
 

 

ITEM 1. LEGAL PROCEEDINGS

31

 

 

 

 

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

31

 

 

 

 

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

32

 

 

 

 

Signatures

33

 

 

 

 

Exhibit Index

34

 



 

PART I.                 FINANCIAL INFORMATION

 

ITEM 1.                  FINANCIAL STATEMENTS

 

THE GENLYTE GROUP INCORPORATED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

FOR THE THREE MONTHS AND NINE MONTHS ENDED OCTOBER 2, 2004 AND SEPTEMBER 27, 2003

(Amounts in thousands, except earnings per share data)

(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

October 2,
2004

 

September 27,
2003

 

October 2,
2004

 

September 27,
2003

 

Net sales

 

$

303,085

 

$

272,769

 

$

881,884

 

$

764,795

 

Cost of sales

 

196,144

 

176,146

 

572,278

 

497,613

 

Gross profit

 

106,941

 

96,623

 

309,606

 

267,182

 

Selling and administrative expenses

 

74,167

 

67,772

 

224,375

 

194,040

 

Gain on settlement of patent litigation

 

 

(8,000

)

 

(8,000

)

Amortization of intangible assets

 

3,472

 

395

 

3,937

 

852

 

Operating profit

 

29,302

 

36,456

 

81,294

 

80,290

 

Interest expense (income), net

 

1,682

 

(128

)

1,509

 

(65

)

Minority interest, net of income taxes

 

2,853

 

10,730

 

18,314

 

23,941

 

Income before income taxes

 

24,767

 

25,854

 

61,471

 

56,414

 

Income tax provision

 

9,444

 

10,084

 

23,758

 

22,002

 

Net income

 

$

15,323

 

$

15,770

 

$

37,713

 

$

34,412

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

1.12

 

$

1.17

 

$

2.77

 

$

2.55

 

Diluted

 

$

1.10

 

$

1.16

 

$

2.72

 

$

2.53

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

13,682

 

13,492

 

13,612

 

13,472

 

Diluted

 

13,934

 

13,645

 

13,865

 

13,576

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

1



 

THE GENLYTE GROUP INCORPORATED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

AS OF OCTOBER 2, 2004 AND DECEMBER 31, 2003

(Amounts in thousands, except share data)

 

 

 

(Unaudited)
October 2,
2004

 

December 31,
2003

 

Assets:

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and cash equivalents

 

$

60,122

 

$

82,136

 

Short-term investments

 

 

70,479

 

Accounts receivable, less allowances for doubtful accounts of $13,537 and $13,456, as of October 2, 2004 and December 31, 2003

 

197,505

 

160,111

 

Inventories:

 

 

 

 

 

Raw materials

 

56,676

 

54,371

 

Work in process

 

18,195

 

17,228

 

Finished goods

 

77,611

 

72,299

 

Total inventories

 

152,482

 

143,898

 

Deferred income taxes and other current assets

 

30,726

 

28,602

 

Total current assets

 

440,835

 

485,226

 

Property, plant and equipment, at cost

 

425,835

 

387,507

 

Less: accumulated depreciation and amortization

 

277,369

 

275,883

 

Net property, plant and equipment

 

148,466

 

111,624

 

Goodwill

 

245,788

 

150,532